Not surprisingly, therefore, oncogenes and tumour-suppressor genes, such as P53, as well as the underlying genetic aberrations in pancreatic cancer have been the subject of intense research (Schleger et al, 2000). The gene discussed is TP53; the disease is familial pancreatic carcinoma.